|
JPS5238680B2
(OSRAM)
|
1972-12-27 |
1977-09-30 |
|
|
|
US4732155A
(en)
|
1985-08-27 |
1988-03-22 |
The Children's Medical Center Corporation |
Implantable chemoattractant system
|
|
US5658894A
(en)
|
1989-04-23 |
1997-08-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for inhibiting restenosis
|
|
US5661127A
(en)
|
1995-05-01 |
1997-08-26 |
The Regents Of The University Of California |
Peptide compositions with growth factor-like activity
|
|
JP3018313B2
(ja)
|
1996-02-23 |
2000-03-13 |
雪印乳業株式会社 |
骨形成促進及び骨吸収防止剤
|
|
US20040031072A1
(en)
*
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
AU778386B2
(en)
|
1999-07-28 |
2004-12-02 |
Board Of Trustees Of The Leland Stanford Junior University |
Nicotine receptor agonists in stem cell and progenitor cell recruitment
|
|
EP1263931A4
(en)
|
1999-11-05 |
2009-07-15 |
Gerigene Medical Corp |
INCREASE AND REPAIR OF IMPERFECTIONS OF SOFT TISSUES RELATED TO AGE
|
|
EP1114862A3
(de)
|
1999-11-17 |
2003-08-06 |
Switch Biotech Aktiengesellschaft |
Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen
|
|
KR20030032922A
(ko)
|
2000-02-24 |
2003-04-26 |
싸이트 테라피스 인코포레이티드 |
세포의 동시 자극 및 농축
|
|
JP3421741B2
(ja)
|
2000-05-18 |
2003-06-30 |
筑波大学長 |
人工骨髄、血球細胞の増殖方法
|
|
US7754217B2
(en)
|
2001-03-16 |
2010-07-13 |
Bio3 Research Srl |
HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases
|
|
WO2002088181A2
(en)
|
2001-04-30 |
2002-11-07 |
Switch Biotech Ag |
Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
|
|
DE10121254A1
(de)
|
2001-04-30 |
2002-11-07 |
Switch Biotech Ag |
MRP8/MRP14 Heterodimers oder seiner Einzelkomponenten alleine oder in Kombination zur Behandlung und/oder Prävention von Hauterkrankungen, Wunden und/oder Wundheilungsstörungen, die durch eine verringerte Menge an MRP8/MRP14 Heterodimeren gekennzeichnet sind
|
|
US7220723B2
(en)
|
2001-05-15 |
2007-05-22 |
The Feinstein Institute For Medical Research |
Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
|
|
US7304034B2
(en)
|
2001-05-15 |
2007-12-04 |
The Feinstein Institute For Medical Research |
Use of HMGB fragments as anti-inflammatory agents
|
|
CZ20033402A3
(cs)
|
2001-05-15 |
2004-10-13 |
Northáshore@Longáislandájewisháresearcháinstitute |
Použití fragmentů HMG jako protizánětlivých činidel
|
|
ITMI20011986A1
(it)
|
2001-09-25 |
2003-03-25 |
San Raffaele Centro Fond |
Metodo e composizione per l'attivazione di cellule presentanti l'antigene
|
|
JPWO2003043651A1
(ja)
|
2001-11-19 |
2005-03-10 |
協和醗酵工業株式会社 |
多分化能幹細胞を組織から末梢血へ動員する薬剤
|
|
EP2305276A3
(en)
|
2001-12-07 |
2011-09-21 |
Cytori Therapeutics, Inc. |
Processed lipoaspirate cells for use in therapy
|
|
FR2833609B1
(fr)
|
2001-12-19 |
2004-12-03 |
Natural Implant |
Dispositif de prelevement cellulaire ou tissulaire en phase active et utilisations
|
|
CN1671742A
(zh)
|
2002-07-03 |
2005-09-21 |
塔博尔山圣拉弗尔基金中心 |
Hmgb1在治疗组织损伤和/或促进组织修复中的用途
|
|
DE60327075D1
(de)
|
2002-07-05 |
2009-05-20 |
Univ Laval |
Der entzündungsreaktionen
|
|
GB0226251D0
(en)
|
2002-11-11 |
2002-12-18 |
San Raffaele Centro Fond |
Acetylated protein
|
|
US20040156851A1
(en)
|
2002-11-20 |
2004-08-12 |
Critical Therapeutics, Inc. |
HMGB1 combination therapies
|
|
AU2003294488B2
(en)
|
2002-11-20 |
2007-05-24 |
Critical Therapeutics, Inc. |
Use of HMGB fragments as anti-inflammatory agents
|
|
WO2004061456A2
(de)
|
2003-01-03 |
2004-07-22 |
Alcedo Biotech Gmbh |
Verwendungen von hmgb, hmgn, hmga proteinen
|
|
WO2004075855A2
(en)
|
2003-02-26 |
2004-09-10 |
Biomed Solutions, Llc |
Process for in vivo treatment of specific biological targets in bodily fluid
|
|
CN1193092C
(zh)
|
2003-03-28 |
2005-03-16 |
浙江大学 |
骨髓间充质干细胞分离和体外扩增培养方法
|
|
DE602004017148D1
(de)
|
2003-03-28 |
2008-11-27 |
Univ Laval |
S100 protein als aktivator neutrophiler zellen zur verminderung der neutropenie bei der krebsbehandlung
|
|
US20090069227A9
(en)
|
2003-04-29 |
2009-03-12 |
Capogrossi Maurizio C |
Use of HMGB1 to promote stem cell migration and/or proliferation
|
|
US20050014255A1
(en)
|
2003-05-29 |
2005-01-20 |
Board Of Regents, The University Of Texas System |
Stem cells for clinical and commercial uses
|
|
WO2005025604A2
(en)
|
2003-09-10 |
2005-03-24 |
The General Hospital Corporation |
Use of hmgb and hmgb fragments to decrease specific immune response
|
|
AU2004272607B2
(en)
|
2003-09-11 |
2008-11-06 |
Cornerstone Therapeutics Inc. |
Monoclonal antibodies against HMGB1
|
|
ITRM20040058A1
(it)
|
2004-02-03 |
2004-05-03 |
Marco E Bianchi |
Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali.
|
|
WO2006008779A1
(en)
|
2004-07-20 |
2006-01-26 |
Provincia Italiana Della Congregazione Dei Figli Dell'immacolata Concezione-Istituto Dermopatico Dell'immacolata |
Use of hmgb1 for wound healing
|
|
MX2007001155A
(es)
|
2004-07-29 |
2007-08-14 |
Creabilis Therapeutics Spa |
Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
|
|
AU2005279308B2
(en)
*
|
2004-09-03 |
2012-05-03 |
Creabilis Therapeutics S.R.L. |
Protease resistant human and non-human HMGB1 Box-A mutants and their therapeutic/diagnostic use
|
|
CA2585043A1
(en)
|
2004-10-22 |
2007-01-04 |
Medimmune, Inc. |
High affinity antibodies against hmgb1 and methods of use thereof
|
|
KR100593397B1
(ko)
|
2004-10-27 |
2006-06-28 |
한국원자력연구소 |
중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
|
|
WO2006047820A1
(en)
|
2004-11-01 |
2006-05-11 |
Newsouth Innovations Pty Limited |
Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation
|
|
ITRM20050032A1
(it)
|
2005-01-21 |
2006-07-22 |
Marco E Bianchi |
Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.
|
|
WO2006080434A1
(ja)
|
2005-01-27 |
2006-08-03 |
Japan Health Sciences Foundation |
間葉系幹細胞を含む細胞シート
|
|
DK1893253T3
(da)
|
2005-03-23 |
2010-08-16 |
Biosafe Sa |
Integreret system til opsamling, forarbejdning og transplantation af celledelmængder, omfattende voksenstamceller til regenerativ medicin
|
|
KR100775958B1
(ko)
*
|
2005-03-30 |
2007-11-13 |
김정문 |
조직재생 기능을 가지는 비활성 폴리펩티드 및 그 제조방법
|
|
WO2006114805A2
(en)
|
2005-04-28 |
2006-11-02 |
Fondazione Centro San Raffaele Del Monte Tabor |
Use of hmgb2 and hmgb3 proteins for medical applications
|
|
US20100280493A1
(en)
|
2005-06-23 |
2010-11-04 |
Asha Nayak |
Methods and Systems for Treating Injured Cardiac Tissue
|
|
WO2007015546A1
(ja)
|
2005-08-04 |
2007-02-08 |
Genomix Co., Ltd |
間葉系幹細胞誘導剤及び組織再生促進剤並びに間葉系幹細胞の調製方法
|
|
WO2007031100A1
(en)
|
2005-09-14 |
2007-03-22 |
Ostini, Marco |
Active immunotherapy of life-threatening systemic inflammation
|
|
WO2007061762A2
(en)
*
|
2005-11-18 |
2007-05-31 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt And Human Services |
Non-viral gene delivery complex
|
|
US7829097B2
(en)
|
2006-02-06 |
2010-11-09 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Use of HMGB1 for protection against ischemia reperfusion injury
|
|
JP4982739B2
(ja)
|
2006-06-01 |
2012-07-25 |
国立大学法人 東京医科歯科大学 |
ポリグルタミン病の予防・治療剤
|
|
US8496931B2
(en)
|
2006-08-11 |
2013-07-30 |
Medarex, Inc. |
Monoclonal antibodies against stromal derived factor-1 (SDF-1)
|
|
WO2008031612A1
(en)
|
2006-09-15 |
2008-03-20 |
Creabilis Therapeutics S.P.A. |
Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1
|
|
ATE505205T1
(de)
*
|
2006-09-15 |
2011-04-15 |
Creabilis Therapeutics Spa |
Polymerkonjugate von box-a von hmgb1 und box-a- varianten von hmgb1
|
|
EP2055308B1
(en)
|
2006-10-30 |
2017-05-10 |
Genomix Co., Ltd. |
Pharmaceutical for promoting functional regeneration of damaged tissue
|
|
CA2629652A1
(en)
|
2007-04-24 |
2008-10-24 |
Yaojiong Wu |
Compositions for preventing or treating skin defects and methods of use thereof
|
|
US8114668B2
(en)
|
2007-05-14 |
2012-02-14 |
Cardiac Pacemakers, Inc. |
Composition for cold storage of stem cells
|
|
AU2009240885A1
(en)
|
2008-04-30 |
2009-11-05 |
Genomix Co., Ltd. |
Pharmaceutical agent for promoting the functional regeneration of damaged tissue
|
|
KR20110017371A
(ko)
|
2008-04-30 |
2011-02-21 |
가부시키가이샤 제노믹스 |
생체내 기능적 세포의 고효율 채취법
|
|
JP5660889B2
(ja)
|
2008-04-30 |
2015-01-28 |
株式会社ジェノミックス |
末梢循環への骨髄由来多能性幹細胞動員薬
|
|
JP2013508013A
(ja)
|
2009-10-16 |
2013-03-07 |
ザ ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー |
細胞療法戦略を用いた慢性神経組織損傷の治療方法
|
|
KR20120135190A
(ko)
|
2009-10-28 |
2012-12-12 |
고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 |
골수 간엽계 및/또는 다능성 줄기세포의 혈중 동원(動員)에 의한 조직 재생 촉진제
|
|
CN102443064A
(zh)
|
2011-11-03 |
2012-05-09 |
刘誉 |
一种基于凝血酶活性的双靶向作用的嵌合多肽及其应用
|
|
RU2647467C2
(ru)
|
2012-10-25 |
2018-03-15 |
Дженомикс Ко., Лтд. |
Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1
|
|
WO2014065348A1
(ja)
|
2012-10-25 |
2014-05-01 |
株式会社ジェノミックス |
Hmgb1断片を利用した脊髄の損傷に対する新規治療法
|